TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and currently hold any of those NASDAQ:INFI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Infinity Pharmaceuticals Inc.
Security
NASDAQ: INFI

Summary

June 27, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was announced over potential breaches of fiduciary duties by certain officers and directors at Infinity Pharmaceuticals.

The investigation by a law firm concerns whether certain Infinity Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.

Infinity Pharmaceuticals Inc. reported that its annual Total Revenue declined from $165 million in 2104 to $109.07 million in 2015 and that its Net Loss increased from $17.42 million in 2014 to $128.38 million in 2015.

Shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) declined from $17.78 per share in December 2014 to as low as $1.24 per share on June 14, 2016.

On June 21, 2016, NASDAQ:INFI shares closed at $1.32 per share.

Start Monitoring Your Investments